Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development

Rutella, S. ORCID: 0000-0003-1970-7375, Bonanno, G. and De Cristofaro, R., 2009. Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development. Endocrine, Metabolic & Immune Disorders - Drug Targets, 9 (2), pp. 151-177. ISSN 1871-5303

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Endocrine, Metabolic & Immune Disorders - Drug Targets
Creators:	Rutella, S., Bonanno, G. and De Cristofaro, R.
Publisher:	Bentham Science Publishers Ltd.
Date:	2009
Volume:	9
Number:	2
ISSN:	1871-5303
Identifiers:	Number Type 10.2174/187153009788452453 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	Jonathan Gallacher
Date Added:	13 Sep 2016 10:50
Last Modified:	09 Jun 2017 14:05
URI:	https://irep.ntu.ac.uk/id/eprint/28490

Actions (login required)

Edit View

Views

Downloads